Last update 30 Jun 2025

Anastrozole/Levonorgestrel

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BAY 98-7196, BAY-98-7196, BAY98-7196
Target
PR x aromatase
Action
agonists, inhibitors
Mechanism
PR agonists(Progesterone receptor agonists), aromatase inhibitors(Aromatase inhibitors)
Therapeutic Areas
Other DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
ContraceptionEndometriosis
Originator Organization
Bayer AGBayer AG
Active Organization-
Inactive Organization
Bayer AGBayer AG
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H28O2
InChIKeyWWYNJERNGUHSAO-XUDSTZEESA-N
CAS Registry797-63-7
View All Structures (2)

Related

2
Clinical Trials associated with Anastrozole/Levonorgestrel
NCT02545452
/ CompletedPhase 1
A Parallel Group, Randomized, Open-label Study to Investigate the Effect of the Intravaginally Administered Antimycotic Miconazole, Antibiotic Clindamycin, Spermicide Nonoxynol-9, or Co-usage of Tampons on 3 Consecutive Days on the Pharmacokinetics of Anastrozole and Levonorgestrel Released From an Intra-vaginal Ring in Healthy Young Women
NCT02403401
/ CompletedPhase 3
Multi-center, Open-label, Single-arm Study to Assess the Safety and Contraceptive Efficacy of a Levonorgestrel-containing Intravaginal Ring During a Treatment Period of One Year in Healthy Women 18 to 35 Years of Age
100 Clinical Results associated with Anastrozole/Levonorgestrel
Login to view more data
100 Translational Medicine associated with Anastrozole/Levonorgestrel
Login to view more data
100 Patents (Medical) associated with Anastrozole/Levonorgestrel
Login to view more data
100 Deals associated with Anastrozole/Levonorgestrel
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ContraceptionPhase 3
United States
Bayer AGBayer AG
15 May 2015
ContraceptionPhase 3
Japan
Bayer AGBayer AG
15 May 2015
EndometriosisPhase 1
Germany
Bayer AGBayer AG
15 Sep 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free